1. Home
  2. SCLX vs AUID Comparison

SCLX vs AUID Comparison

Compare SCLX & AUID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • AUID
  • Stock Information
  • Founded
  • SCLX 2011
  • AUID 2009
  • Country
  • SCLX United States
  • AUID United States
  • Employees
  • SCLX N/A
  • AUID N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • AUID Computer Software: Prepackaged Software
  • Sector
  • SCLX Health Care
  • AUID Technology
  • Exchange
  • SCLX Nasdaq
  • AUID Nasdaq
  • Market Cap
  • SCLX 35.7M
  • AUID 35.6M
  • IPO Year
  • SCLX N/A
  • AUID N/A
  • Fundamental
  • Price
  • SCLX $16.46
  • AUID $2.82
  • Analyst Decision
  • SCLX Buy
  • AUID
  • Analyst Count
  • SCLX 2
  • AUID 0
  • Target Price
  • SCLX $245.00
  • AUID N/A
  • AVG Volume (30 Days)
  • SCLX 255.7K
  • AUID 116.7K
  • Earning Date
  • SCLX 08-13-2025
  • AUID 11-06-2025
  • Dividend Yield
  • SCLX N/A
  • AUID N/A
  • EPS Growth
  • SCLX N/A
  • AUID N/A
  • EPS
  • SCLX N/A
  • AUID N/A
  • Revenue
  • SCLX $44,236,000.00
  • AUID $2,189,524.00
  • Revenue This Year
  • SCLX $89.26
  • AUID N/A
  • Revenue Next Year
  • SCLX $203.95
  • AUID N/A
  • P/E Ratio
  • SCLX N/A
  • AUID N/A
  • Revenue Growth
  • SCLX N/A
  • AUID 295.86
  • 52 Week Low
  • SCLX $3.60
  • AUID $2.20
  • 52 Week High
  • SCLX $39.90
  • AUID $9.58
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 47.62
  • AUID 49.74
  • Support Level
  • SCLX $13.08
  • AUID $2.36
  • Resistance Level
  • SCLX $14.74
  • AUID $2.58
  • Average True Range (ATR)
  • SCLX 1.51
  • AUID 0.25
  • MACD
  • SCLX -0.07
  • AUID 0.04
  • Stochastic Oscillator
  • SCLX 55.24
  • AUID 79.42

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

Share on Social Networks: